It is our pleasure to invite you to participate in The American Conference on Controversies on Cannabis-Based Medicines (Med-CannabisUSA) which will take place January 23-24, 2020 in Orlando, Florida.
Med-CannabisUSA will address the many controversies surrounding cannabis-based medicines.
Strong public and patient demand has led to the decision to allow cannabis products for medical use all over the world. There is a rapidly-growing basic-science and clinical research literature providing insight into potential use of cannabis products for chronic pain, cancer management, and many other medical areas. Growing concerns and controversies focusing on overly-optimistic therapeutic claims and potential harms parallel recent expanded access to cannabis.
Our world renowned panel of experts will explore many of these controversial issues like “The place of cannabinoids in the ongoing opioid crisis”, “The therapeutic value of cannabinoids in psychiatric and neurological disease” as well as many other provocative and timely topics.
This Conference will bring together researchers, clinicians, industry professionals and national cannabis agencies to update the current state of knowledge and elucidate key controversies in order to provide clarity and guidance going forward for all involved and interested in the potential of cannabis based medicines.
Conference highlights will include:
• Cannabis: Neurology and its Effects on the Brain
• Brain Disorders & Therapeutics
• Cannabis & Psychiatry
• The Cannabis and Opioid Use Controversy
• Cannabis Use Disorder
• Cannabis Use and Driving
• Social Effects of Cannabis
• Toxicity and Patient Safety
• Therapeutics and other Uses
• Cannabis – Effects on Lung Health
• Treatment & Rehabilitation
• Advanced Research on Cannabis
• Case Reports
We look forward to seeing you at Med-CannabisUSA in Orlando.
Prof. Dr. Perry G. Fine
University of Utah, USA
Dr. Silviu Brill
Tel Aviv Medical Center, Israel